195 related articles for article (PubMed ID: 22022583)
21. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
[TBL] [Abstract][Full Text] [Related]
22. Loss of the tumor suppressor PML in human cancers of multiple histologic origins.
Gurrieri C; Capodieci P; Bernardi R; Scaglioni PP; Nafa K; Rush LJ; Verbel DA; Cordon-Cardo C; Pandolfi PP
J Natl Cancer Inst; 2004 Feb; 96(4):269-79. PubMed ID: 14970276
[TBL] [Abstract][Full Text] [Related]
23. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML).
Grötzinger T; Sternsdorf T; Jensen K; Will H
Eur J Biochem; 1996 Jun; 238(2):554-60. PubMed ID: 8681971
[TBL] [Abstract][Full Text] [Related]
24. The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.
Guan D; Factor D; Liu Y; Wang Z; Kao HY
Oncogene; 2013 Aug; 32(33):3819-28. PubMed ID: 22945642
[TBL] [Abstract][Full Text] [Related]
25. Promyelocytic leukemia (PML) protein plays important roles in regulating cell adhesion, morphology, proliferation and migration.
Tang MK; Liang YJ; Chan JY; Wong SW; Chen E; Yao Y; Gan J; Xiao L; Leung HC; Kung HF; Wang H; Lee KK
PLoS One; 2013; 8(3):e59477. PubMed ID: 23555679
[TBL] [Abstract][Full Text] [Related]
26. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
[TBL] [Abstract][Full Text] [Related]
27. Microtubule-associated protein 1 light chain 3 interacts with and contributes to growth inhibiting effect of PML.
He W; Hu CX; Hou JK; Fan L; Xu YW; Liu MH; Yan SY; Chen GQ; Huang Y
PLoS One; 2014; 9(11):e113089. PubMed ID: 25419843
[TBL] [Abstract][Full Text] [Related]
28. PML: a tumor suppressor that regulates cell fate in mammary gland.
Li W; Rich T; Watson CJ
Cell Cycle; 2009 Sep; 8(17):2711-7. PubMed ID: 19652541
[TBL] [Abstract][Full Text] [Related]
29. The interferon-induced antiviral protein PML (TRIM19) promotes the restriction and transcriptional silencing of lentiviruses in a context-specific, isoform-specific fashion.
Masroori N; Merindol N; Berthoux L
Retrovirology; 2016 Mar; 13():19. PubMed ID: 27000403
[TBL] [Abstract][Full Text] [Related]
30. The promyelocytic leukemia protein represses A20-mediated transcription.
Wu WS; Xu ZX; Chang KS
J Biol Chem; 2002 Aug; 277(35):31734-9. PubMed ID: 12080044
[TBL] [Abstract][Full Text] [Related]
31. Promyelocytic Leukemia (PML) Gene Mutations may not Contribute to Gastric Adenocarcinoma Development.
Imani-Saber Z; Yousefi-Razin E; Javaheri M; Mirfakhraie R; Motalleb G; Ghafouri-Fard S
Asian Pac J Cancer Prev; 2015; 16(8):3523-5. PubMed ID: 25921172
[TBL] [Abstract][Full Text] [Related]
32. PML promotes MHC class II gene expression by stabilizing the class II transactivator.
Ulbricht T; Alzrigat M; Horch A; Reuter N; von Mikecz A; Steimle V; Schmitt E; Krämer OH; Stamminger T; Hemmerich P
J Cell Biol; 2012 Oct; 199(1):49-63. PubMed ID: 23007646
[TBL] [Abstract][Full Text] [Related]
33. HDAC is indispensable for IFN-γ-induced B7-H1 expression in gastric cancer.
Deng R; Zhang P; Liu W; Zeng X; Ma X; Shi L; Wang T; Yin Y; Chang W; Zhang P; Wang G; Tao K
Clin Epigenetics; 2018 Dec; 10(1):153. PubMed ID: 30537988
[TBL] [Abstract][Full Text] [Related]
34. PML is a key component for the differentiation of myeloid progenitor cells to macrophages.
Khalfin-Rabinovich Y; Weinstein A; Levi BZ
Int Immunol; 2011 Apr; 23(4):287-96. PubMed ID: 21427174
[TBL] [Abstract][Full Text] [Related]
35. PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool.
Li W; Ferguson BJ; Khaled WT; Tevendale M; Stingl J; Poli V; Rich T; Salomoni P; Watson CJ
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4725-30. PubMed ID: 19261859
[TBL] [Abstract][Full Text] [Related]
36. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects.
Chee AV; Lopez P; Pandolfi PP; Roizman B
J Virol; 2003 Jun; 77(12):7101-5. PubMed ID: 12768029
[TBL] [Abstract][Full Text] [Related]
37. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation.
Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC
Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547
[TBL] [Abstract][Full Text] [Related]
38. Stimulatory role of interleukin 10 in CD8
Xi J; Xu M; Song Z; Li H; Xu S; Wang C; Song H; Bai J
Tumour Biol; 2017 May; 39(5):1010428317706209. PubMed ID: 28488547
[TBL] [Abstract][Full Text] [Related]
39. PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR.
Bernardi R; Guernah I; Jin D; Grisendi S; Alimonti A; Teruya-Feldstein J; Cordon-Cardo C; Simon MC; Rafii S; Pandolfi PP
Nature; 2006 Aug; 442(7104):779-85. PubMed ID: 16915281
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor alpha transcriptionally activates casein kinase 2 alpha: A pivotal regulator of promyelocytic leukaemia protein (PML) and AKT in oncogenesis.
Das N; Datta N; Chatterjee U; Ghosh MK
Cell Signal; 2016 Jun; 28(6):675-87. PubMed ID: 27012497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
